NCT07123909View on ClinicalTrials.gov

Studies on Adsorption International Learning Initiative Global

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
CKD (Chronic Kidney Disease) Stage 5DUremia; ChronicUremic; ToxemiaInflammation ChronicHemodialysisInflammation BiomarkersDialysis Related ComplicationAnemia Associated With End Stage Renal Disease
Interventions
DEVICE

Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafron HA130 contains the original adsorbing material.

The test cartridge will be used in addition to the ongoing program hemodialysis three times a week in the first month, twice a week in the next month, once a week in the third month

Trial Locations (1)

Unknown

RECRUITING

Botkin Hospital, Moscow

All Listed Sponsors
lead

Botkin Hospital

OTHER

NCT07123909 - Studies on Adsorption International Learning Initiative Global | Biotech Hunter | Biotech Hunter